Last updated on July 2020

Impact of the Arrival on the French Market of New First Line Oral Treatments on the Delay Between MS Onset and First Disease Modifying Treatment (DMTs) Administration

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: C10.114.375.500
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients registered in EDMUS database.
  • Patients with an initial and definite diagnosis of Relapsing-Remitting Multiple Sclerosis.
  • An established diagnosis from January 1st 1995 to the end of the study.

Exclusion Criteria:

  • Patients not registered in EDMUS database.
  • Patient with a diagnosis of Primary Progressive Multiple Sclerosis
  • Patients with a diagnosis established before January 1st 1995

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.